Investor Relations

Invest in the Future of
Bio-Intelligence

GeneOn Biotech is revolutionizing drug discovery by combining Proprietary Data, AI, and Quantum Mechanics.

Owning the world’s largest peptide interaction library (200K). We generate the “Ground Truth” data that AI craves.

A validated technology engine combining Microarray, AI, and Quantum computing. Proven by 160+ clients.

Robust business model transitioning from stable CRO revenue to high-value Drug Licensing (L/O).

Financial Growth

We are maintaining a steep growth trajectory based on stable service revenue and expanding government R&D projects.

30%
CAGR (Revenue)

$5M+
Cumulative Funding

[ Financial Growth Graph Area ]
Upload your Chart Image here

Access our detailed investor presentation (Non-confidential) to learn more about our technology and roadmap.

Name

Company / VC

Business Email

* We’ll send the deck to your email within 24hrs.

For detailed financial inquiries or partnership proposals.